Fierce Biotech regularly pulls together the industry’s top money raisers from the year before. Staff writer Gabrielle Masson and Editor-in-Chief Ayla Ellison discuss a few of the biotechs at the top of the list.
Plus, in this episode, we cover Johnson & Johnson's talc litigation, prison plans for Elizabeth Holmes and more of this week's top headlines.
To learn more about the topics in this episode:
- Biotech's top money raisers of 2022
- Johnson & Johnson's $8.9B bankruptcy settlement is 'unworkable,' talc plaintiff lawyer says
- Theranos' Elizabeth Holmes must report to prison this month despite pending appeal, judge rules
- FDA dubs Abbott's FreeStyle Libre battery issues a Class I recall, spanning 4.2M devices
- Philips re-recalls 1,200 CPAP, BiPAP machines repaired in far-reaching ventilator probe
- Activist investor Icahn calls for Illumina CEO to be voted off company board over Grail deal
- Moderna's mRNA flu shot struggles to prove its worth again in phase 3 trial
- Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
- After last year's cuts, Biogen kicks off another round of layoffs
The Top Line is produced by senior podcast producer Teresa Carey and managing editor Querida Anderson. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.